Pure Global AI
ANVISA registration 10387650140Active

Instrument for analysis of general biochemistry, hormones, drugs or proteins

ANVISA Registration Number: 10387650140CAPRICORN TECHNOLOGIES DO BRASIL LTDADXGEN CORP.Risk Class II
Verified
Device names
Technical name
Instrument for analysis of general biochemistry, hormones, drugs or proteins
View exact technical-name matches →
PT: Instrumento para análise de bioquímica geral, hormônios, drogas ou proteínas
Commercial name
Epithod® 414 AutoDx
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10387650140
Process Number
25351194956202317
CNPJ
02823683000102
Company information
Registration Holder
CAPRICORN TECHNOLOGIES DO BRASIL LTDA
Manufacturer
DXGEN CORP.
Manufacturing Country
South Korea
PT: CORÉIA DO SUL
Dates and status
Publication Date
May 02, 2023
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for Instrument for analysis of general biochemistry, hormones, drugs or proteins in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650140 and manufactured by DXGEN CORP.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.